Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 27,428 $ 25,668
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 4,090 3,105
Costs recognized on sale of acquired inventory 1,731 1,264
Deferred income taxes (1,329) (777)
Stock-based compensation expense 569 303
Excess tax benefit from stock option exercises (4) (1)
Losses by equity method investees 0 41
Other 124 107
Change in operating assets and operating liabilities, net of acquisition:    
Trade accounts and other receivables (106) 1,053
Inventories (296) (1,084)
Prepaid expenses (305) (252)
Trade accounts payable and accrued expenses (828) 218
Salaries, wages and related accruals 1,420 400
Income taxes payable 91 (782)
Net cash provided by operating activities 32,585 29,263
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition, net of cash acquired (103,049) 0
Purchase of available-for-sale investments (27,010) (21,119)
Proceeds from sales of available-for-sale investments 12,700 6,200
Proceeds from maturities of available-for-sale investments 16,090 11,601
Additions to property and equipment (3,811) (2,515)
Distribution from unconsolidated entity 85 0
Increase in other long-term assets (138) (87)
Net cash used in investing activities (105,133) (5,920)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (11,051) (10,312)
Proceeds from stock option exercises 1,145 136
Excess tax benefit from stock option exercises 4 1
Purchase of common stock for stock bonus plans 0 (573)
Net cash used in financing activities (9,902) (10,748)
Effect of exchange rate changes on cash and cash equivalents 2,520 1,535
Net increase in cash and cash equivalents (79,930) 14,130
Cash and cash equivalents at beginning of period 163,786 116,675
Cash and cash equivalents at end of period $ 83,856 $ 130,805